Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Hepatic encephalopathy: a dynamic or static condition.

Charmaine A Stewart1, Jane Cerhan

  • 1Division of Gastroenterology and Hepatology, Mayo Clinic Rochester, Rochester, MN 55905, USA.

Metabolic Brain Disease
|September 17, 2005
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Phase I/II trial of vorinostat combined with temozolomide and radiation therapy for newly diagnosed glioblastoma: results of Alliance N0874/ABTC 02.

Neuro-oncology·2017
Same author

The effects of poor sleep quality on cognitive function of patients with cirrhosis.

Journal of clinical sleep medicine : JCSM : official publication of the American Academy of Sleep Medicine·2014
Same author

The cognitive profile of depressed patients with cirrhosis.

The primary care companion for CNS disorders·2011
Same author

Development of a three-factor neuropsychological approach for detecting minimal hepatic encephalopathy.

Liver international : official journal of the International Association for the Study of the Liver·2010
Same author

Preliminary report of the Hepatic Encephalopathy Assessment Driving Simulator (HEADS) score.

Ethnicity & disease·2008
Same author

Minimal hepatic encephalopathy.

Nature clinical practice. Gastroenterology & hepatology·2007
Same journal

The protective role of melatonin on the brain in a rat model of Alzheimer's disease.

Metabolic brain disease·2026
Same journal

Neuroprotective effects of 2-(2-nitrophenyl)-1,3-thiazolidine-4-carboxylic acid in a rotenone-induced Parkinson's disease rat model: Modulation of oxidative stress, behavioral dysfunction, and iron accumulation.

Metabolic brain disease·2026
Same journal

Gestational deltamethrin exposure exacerbates post-traumatic epileptiform activity and social deficits, diminishing the therapeutic efficacy of curcumin in rats.

Metabolic brain disease·2026
Same journal

The interplay between gut microbiota and Alzheimer's disease: mechanistic insights from dysbiosis to disease modulation.

Metabolic brain disease·2026
Same journal

Bushen Huoxue Acupuncture alleviates alzheimer's disease progression via the E3 ubiquitin ligase SMURF2‑mediated ubiquitination of LAPTM5.

Metabolic brain disease·2026
Same journal

Gut-brain axis modulation by fecal microbiota transplantation improves dual-organ injury after cerebral ischemia-reperfusion via Caspase-8 dependent inhibition of necroptosis.

Metabolic brain disease·2026
See all related articles

Hepatic encephalopathy (HE) is a brain dysfunction linked to liver disease. This review explores HE mechanisms and discusses whether liver transplantation fully reverses its effects.

Area of Science:

  • Neuroscience
  • Gastroenterology
  • Hepatology

Background:

  • Hepatic encephalopathy (HE) is a neuropsychiatric disorder associated with portal hypertension.
  • Current management focuses on reducing gastrointestinal ammonia or liver transplantation.
  • The complete reversibility of HE after liver transplantation remains unclear.

Purpose of the Study:

  • To review the underlying mechanisms of hepatic encephalopathy.
  • To evaluate the pros and cons of HE reversibility, particularly after liver transplantation.

Main Methods:

  • Literature review of studies on HE mechanisms.
  • Analysis of current therapeutic strategies for HE.
  • Discussion of outcomes related to liver transplantation in HE patients.

Related Experiment Videos

Main Results:

  • HE mechanisms involve complex neurobiological pathways.
  • Ammonia reduction strategies offer symptomatic relief.
  • Liver transplantation may not fully resolve all HE manifestations.

Conclusions:

  • Understanding HE mechanisms is crucial for targeted therapies.
  • Liver transplantation is a definitive treatment but may not guarantee complete HE reversal.
  • Further research is needed to address residual HE symptoms post-transplantation.